ADVANCED CELL THERAPY AND RESEARCH INSTITUTE, SINGAPORE
Last Updated: 13 Apr 2026
ACTRIS was established in April 2020 to meet the increasing clinical demand for cellular therapeutics to treat various life-threatening diseases.
Our vision is to be the national and regional centre of excellence for facilitating discovery, process development, and manufacturing of cellular-based therapeutics across the broad spectrum of immunotherapy and regenerative medicine, encompassing both investigational and clinical-use products for Singapore.
Through its specialised infrastructure and skilled workforce, ACTRIS aims to promote and support the entire value chain of the cell therapy ecosystem by enabling translational research and development, manufacturing, clinical service provision, and commercialisation across the healthcare, academic and industrial sectors.
In addition, ACTRIS will also provide value-added services such as workforce training, regulatory support, and the standardisation of ancillary materials and product testing pertaining to the delivery of cellular therapy to patients.
ACTRIS is a programme of CRIS.
Country of registration | Singapore |
Registration number | 53412298A |
Local SIC | |
Incorporation date | 20 Apr 2020 |
Company age | 6 years 2 months |
Official entity type | Sole Proprietor |
No. of officers | 1 |
Contact
Address:
23 ROCHESTER PARK, #06-01, Singapore 139234
Access Key Decision Makers
This is the legal entity page of ADVANCED CELL THERAPY AND RESEARCH INSTITUTE, SINGAPORE. To access company info, company size, news , key makers’ emails, visit the profile pages above.
Associated business (1)
- View MoreACTRIS was established in April 2020 to meet the increasing clinical demand for cellular therapeutics to treat various life-threatening diseases. Our vision is to be the national and regional centre of excellence for facilitating discovery, process development, and manufacturing of cellular-based therapeutics across the broad spectrum of immunotherapy and regenerative medicine, encompassing both investigational and clinical-use products for Singapore. Through its specialised infrastructure and skilled workforce, ACTRIS aims to promote and support the entire value chain of the cell therapy ecosystem by enabling translational research and development, manufacturing, clinical service provision, and commercialisation across the healthcare, academic and industrial sectors. In addition, ACTRIS will also provide value-added services such as workforce training, regulatory support, and the standardisation of ancillary materials and product testing pertaining to the delivery of cellular therapy to patients. ACTRIS is a programme of CRIS.
This is the legal entity page of ADVANCED CELL THERAPY AND RESEARCH INSTITUTE, SINGAPORE. To access company info, company size, news, key maker's emails, visit the profile pages above.
Financials
Revenue | 1 - 10m |
Last updated: 13 Apr 2026
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Discover More Companies
Lookalike companies
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.
Frequently Asked Questions (FAQ)
- What is the address of ADVANCED CELL THERAPY AND RESEARCH INSTITUTE, SINGAPORE?
- Where is ADVANCED CELL THERAPY AND RESEARCH INSTITUTE, SINGAPORE's headquarter?
- What is ADVANCED CELL THERAPY AND RESEARCH INSTITUTE, SINGAPORE's contact number?
- What ADVANCED CELL THERAPY AND RESEARCH INSTITUTE, SINGAPORE's spending power?
- Does ADVANCED CELL THERAPY AND RESEARCH INSTITUTE, SINGAPORE have a presence in the domain it operates in?